NodThera Revenue and Competitors
Estimated Revenue & Valuation
- NodThera's estimated annual revenue is currently $5M per year.
- NodThera's estimated revenue per employee is $155,000
Employee Data
- NodThera has 32 Employees.
- NodThera grew their employee count by 0% last year.
NodThera's People
Name | Title | Email/Phone |
---|---|---|
1 | CEO | Reveal Email/Phone |
2 | VP Chemistry | Reveal Email/Phone |
3 | VP, Biology | Reveal Email/Phone |
4 | VP Scientific Operations | Reveal Email/Phone |
5 | Chief Medical Officer | Reveal Email/Phone |
6 | Senior Director Translational Science | Reveal Email/Phone |
7 | Chief Development Officer | Reveal Email/Phone |
8 | Senior Director Portfolio & Project Management | Reveal Email/Phone |
9 | Director Clinical Operations | Reveal Email/Phone |
10 | Senior Director Clinical Operations | Reveal Email/Phone |
NodThera Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $81.4M | 375 | 40% | N/A | N/A |
#2 | $16.9M | 109 | 22% | N/A | N/A |
#3 | $156.1M | 120 | -70% | $145M | N/A |
#4 | $2.9M | 37 | -24% | $150M | N/A |
#5 | $1.3M | 17 | 0% | $459.5M | N/A |
#6 | $49.2M | 254 | 15% | $180.7M | N/A |
#7 | $7M | 45 | -2% | N/A | N/A |
#8 | $256.3M | 840 | 9% | $168.5M | N/A |
#9 | $4.2M | 27 | -7% | N/A | N/A |
#10 | $10.1M | 65 | 5% | N/A | N/A |
What Is NodThera?
NodThera is developing a new class of potent and highly selective NLRP3 inflammasome inhibitors for the treatment of diseases driven by chronic inflammation. We're building a dynamic team of people across our offices in Cambridge, UK; Seattle, WA; and Lexington, MA; all united by our shared ambition, enthusiasm and creativity.
keywords:N/AN/A
Total Funding
32
Number of Employees
$5M
Revenue (est)
0%
Employee Growth %
N/A
Valuation
N/A
Accelerator
NodThera News
2022-03-30 - Rough biotech market won't stop 5AM Ventures' new $750M ...
... materials research company Halio, biotech NodThera, medical device company Semprus, and biopharmaceutical company Pear Therapeutics.
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $2.5M | 32 | 88% | $15M |